Study for chromosome 9p deletion syndrome
Part of Genetic & congenital clinical trials.
This study looks at people who have “9p minus” syndrome, meaning part of chromosome 9 is missing. It aims to understand how genetic differences may affect symptoms, and it may include family members for comparison.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have 9p minus syndrome (a missing piece of chromosome 9)
- The missing chromosome part must be confirmed by genetic testing or diagnosis
- If you’re a parent or sibling, you must be closely related to someone with 9p minus syndrome
- There are no listed exclusion reasons, so you may still be able to join if you meet the genetic or family criteria
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how brain development and behavior may differ in people with a 3q29 deletion or 3q29 duplication. It may help researchers understand what to expect and how these conditions affect daily life.
This study looks at how genetic differences affect how severe 22q11.2 deletion syndrome is for different people. It may help researchers understand what drives symptom severity and guide future care.
This study is for people who have a rare syndrome or rare congenital condition and are seen at a rare-disease clinic. It aims to better understand these conditions and how care works in a team setting, which may help guide future treatment decisions.
This trial looks at how thinking and mental health (psychiatric symptoms) show up in people who have a specific chromosome deletion. It may help researchers understand patterns in this condition and improve future care.
This study follows infants and young children with conditions caused by having an extra sex chromosome (like XXY, XYY, or XXX) to learn how health and development unfold over time. It may help families and doctors understand what to expect and what support could be helpful.
This study uses a new technique called optical mapping to better understand chromosome changes found in children with neurodevelopmental disorders. It aims to give clearer answers to families about these genetic findings.
Hear when a new Chromosome 9P Deletion Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.